NCT04790812View on ClinicalTrials.gov

Preemptive Analgesia With Celecoxib for Acute Dental Pain Management

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Pain, Postoperative
Interventions
DRUG

Celecoxib

Single, preemptive oral dose 200mg of celecoxib. A cyclooxygenase-2 (COX-2) selective inhibitor for pain management. A COX-2 selective nonsteroidal anti-inflammatory drug (NSAID).

DRUG

Acetaminophen

Single, preemptive oral dose 1000mg of acetaminophen. An over-the-counter medication for pain management.

DRUG

Placebo

A capsule with no active ingredients designed to mimic the appearance of the acetaminophen capsule to ensure blinding of patients and care providers.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER